Crossover study comparing bioavailability of a capsule formulation of the glucagon receptor antagonist LGD-6972 to an oral solution formulation in healthy subjects

被引：0
|
作者：
Pipkin, J. D. [1 ]
Vajda, E. [1 ]
Biernat, L. [2 ]
Klein, D. J. [2 ]
Li, Y. -X. [2 ]
Zangmeister, M. [2 ]
Zhou, R. [2 ]
Zhi, L. [1 ]
Marschke, K. [1 ]
机构：
[1] Ligand Pharmaceut Inc, San Diego, CA USA
[2] Medpace Inc, Cincinnati, OH USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
863
引用
收藏
页码：S399 / S400
页数：2
相关论文
共 50 条
  • [41] Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunteers: Effects of Coadministration With Rosuvastatin, Formulation and Food on Oral Bioavailability
    Ericsson, Hans
    Nelander, Karin
    Heijer, Maria
    Kjaer, Magnus
    Lindstedt, Eva-Lotte
    Albayaty, Muna
    Forte, Pablo
    Lagerstrom-Fermer, Maria
    Skrtic, Stanko
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (03): : 411 - 421
  • [42] Relative bioavailability of three modified release formulations of Lecozotan, a novel 5HT1A antagonist, in comparison to the immediate release formulation in healthy subjects.
    Raje, SV
    Parks, V
    Plotka, A
    Patat, AA
    Dupain, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P45 - P45
  • [43] A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV-0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers
    Qureshi, Irfan
    Lovegren, Meghan
    Wirtz, Victoria
    Larouche, Richard
    Tanguay, Mario
    Anderson, Matt S.
    Hartmann, Sonja
    Coric, Vlad
    Berman, Robert M.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (04): : 476 - 485
  • [44] An open-label, randomized, crossover study to evaluate the bioavailability of nanoemulsion versus conventional fat-soluble formulation of cholecalciferol in healthy participants
    Marwaha, Raman Kumar
    Verma, Manish
    Walekar, Ajit
    Sonawane, Rakesh
    Trivedi, Chirag
    JOURNAL OF ORTHOPAEDICS, 2023, 35 : 64 - 68
  • [45] Bioequivalence Study of Single-Pill Capsule Formulation of Amlodipine Plus Benazepril in Healthy Chinese Subjects Under Fasting and Fed Conditions
    Song, Haojing
    Qiu, Bo
    Sun, Xue
    Guo, Caihui
    Hu, Yiting
    Dong, Zhanjun
    Liu, Yang
    Bai, Wanjun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1853 - 1868
  • [46] Relative bioavailability and pharmacokinetic (PK) performance of a ralinepag extended-release (XR) tablet oral formulation and the effect of food and gender in healthy human subjects
    Adams, J.
    Blackburn, A.
    Parsley, E.
    Tang, Y.
    King, C.
    Grundy, J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 634 - 634
  • [47] Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: a randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects
    Patino-Rodriguez, Omar
    Maria Martinez-Medina, Rosa
    Torres-Roque, Irma
    Martinez-Delgado, Maricela
    Susana Mares-Garcia, America
    Escobedo-Moratilla, Abraham
    Covarrubias-Pinedo, Amador
    Arzola-Paniagua, Angelica
    Luis Herrera-Torres, Jose
    Perez-Urizar, Jose
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [48] Comparative Bioavailability Study of a New Orodispersible Formulation of Ibuprofen Versus Two Existing Oral Tablet Formulations in Healthy Male and Female Volunteers
    Sugar, Dalma
    Francombe, Danielle
    da Silva, Tiago
    Hanid, Sarah
    Hutchings, Simon
    CLINICAL THERAPEUTICS, 2019, 41 (08) : 1486 - 1498
  • [49] Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Crossover Study in Healthy Subjects
    Critchley, David John
    Aluri, Jagadeesh
    Boyd, Peter
    Whayman, Matthew
    Narurkar, Milind
    Delargy, Hugh
    Bibbiani, Francesco
    CLINICAL THERAPEUTICS, 2011, 33 (01) : 146 - 157
  • [50] Single-dose, four-way crossover, open-label, relative bioavailability (BA) studies of a novel formulation of abiraterone acetate (AA) versus the reference formulation under fasted conditions in healthy male subjects.
    Goldwater, Ronald
    Hussaini, Azra
    Zhang, Yuxin
    Bosch, Bill
    Nemeth, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345